CN107259530A - 一种用于安神、改善睡眠的百香果配方食品 - Google Patents
一种用于安神、改善睡眠的百香果配方食品 Download PDFInfo
- Publication number
- CN107259530A CN107259530A CN201710450308.XA CN201710450308A CN107259530A CN 107259530 A CN107259530 A CN 107259530A CN 201710450308 A CN201710450308 A CN 201710450308A CN 107259530 A CN107259530 A CN 107259530A
- Authority
- CN
- China
- Prior art keywords
- parts
- passion fruit
- sleep
- nerves
- fushen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000288157 Passiflora edulis Species 0.000 title claims abstract description 59
- 235000000370 Passiflora edulis Nutrition 0.000 title claims abstract description 59
- 235000013305 food Nutrition 0.000 title claims abstract description 54
- 210000005036 nerve Anatomy 0.000 title claims abstract description 36
- 241000756137 Hemerocallis Species 0.000 claims abstract description 42
- 244000062793 Sorghum vulgare Species 0.000 claims abstract description 41
- 235000019713 millet Nutrition 0.000 claims abstract description 41
- 235000020238 sunflower seed Nutrition 0.000 claims abstract description 38
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 37
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 31
- 235000020234 walnut Nutrition 0.000 claims abstract description 31
- 241000628997 Flos Species 0.000 claims abstract description 29
- 230000001914 calming effect Effects 0.000 claims abstract description 12
- 235000013399 edible fruits Nutrition 0.000 claims description 38
- 238000001035 drying Methods 0.000 claims description 36
- 240000000249 Morus alba Species 0.000 claims description 31
- 241000758789 Juglans Species 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000002994 raw material Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 9
- 206010013786 Dry skin Diseases 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 208000005156 Dehydration Diseases 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 230000018044 dehydration Effects 0.000 claims description 5
- 238000006297 dehydration reaction Methods 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 52
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 27
- 206010022437 insomnia Diseases 0.000 abstract description 23
- 239000008280 blood Substances 0.000 abstract description 22
- 210000004369 blood Anatomy 0.000 abstract description 21
- 230000036541 health Effects 0.000 abstract description 20
- 210000004556 brain Anatomy 0.000 abstract description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 16
- 201000010099 disease Diseases 0.000 abstract description 14
- 210000002784 stomach Anatomy 0.000 abstract description 14
- 208000002173 dizziness Diseases 0.000 abstract description 12
- 210000000952 spleen Anatomy 0.000 abstract description 12
- 238000011161 development Methods 0.000 abstract description 9
- 230000001256 tonic effect Effects 0.000 abstract description 9
- 238000005728 strengthening Methods 0.000 abstract description 8
- 241000218231 Moraceae Species 0.000 abstract description 7
- 230000000994 depressogenic effect Effects 0.000 abstract description 6
- 230000004438 eyesight Effects 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 6
- 210000001835 viscera Anatomy 0.000 abstract description 6
- 208000019901 Anxiety disease Diseases 0.000 abstract description 5
- 208000007443 Neurasthenia Diseases 0.000 abstract description 5
- 230000036506 anxiety Effects 0.000 abstract description 5
- 206010003549 asthenia Diseases 0.000 abstract description 5
- 230000023597 hemostasis Effects 0.000 abstract description 5
- 206010019233 Headaches Diseases 0.000 abstract description 4
- 208000009205 Tinnitus Diseases 0.000 abstract description 4
- 230000036528 appetite Effects 0.000 abstract description 4
- 235000019789 appetite Nutrition 0.000 abstract description 4
- 231100000869 headache Toxicity 0.000 abstract description 4
- 230000003020 moisturizing effect Effects 0.000 abstract description 4
- 238000002560 therapeutic procedure Methods 0.000 abstract description 4
- 231100000886 tinnitus Toxicity 0.000 abstract description 4
- 208000028017 Psychotic disease Diseases 0.000 abstract description 3
- 238000001816 cooling Methods 0.000 abstract description 3
- 230000002950 deficient Effects 0.000 abstract description 3
- 208000019116 sleep disease Diseases 0.000 abstract description 3
- 208000020685 sleep-wake disease Diseases 0.000 abstract description 3
- 230000002936 tranquilizing effect Effects 0.000 abstract description 2
- 240000007049 Juglans regia Species 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000006870 function Effects 0.000 description 25
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 21
- 241000282414 Homo sapiens Species 0.000 description 20
- 235000019197 fats Nutrition 0.000 description 17
- 229910052700 potassium Inorganic materials 0.000 description 14
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 13
- 239000002253 acid Substances 0.000 description 13
- 150000001720 carbohydrates Chemical class 0.000 description 13
- 235000014633 carbohydrates Nutrition 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 13
- 239000011591 potassium Substances 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 235000016709 nutrition Nutrition 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 239000011575 calcium Substances 0.000 description 11
- 229910052791 calcium Inorganic materials 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 10
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 206010028980 Neoplasm Diseases 0.000 description 10
- 229910052742 iron Inorganic materials 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 235000015097 nutrients Nutrition 0.000 description 10
- 208000004880 Polyuria Diseases 0.000 description 9
- 230000009286 beneficial effect Effects 0.000 description 9
- 230000035619 diuresis Effects 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 240000007594 Oryza sativa Species 0.000 description 8
- 235000007164 Oryza sativa Nutrition 0.000 description 8
- 230000018109 developmental process Effects 0.000 description 8
- 230000036651 mood Effects 0.000 description 8
- 235000009566 rice Nutrition 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 201000011510 cancer Diseases 0.000 description 7
- 235000013601 eggs Nutrition 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000009835 boiling Methods 0.000 description 6
- 210000000038 chest Anatomy 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 235000015203 fruit juice Nutrition 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 239000011701 zinc Substances 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 206010057315 Daydreaming Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 206010016256 fatigue Diseases 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000001629 suppression Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 235000019155 vitamin A Nutrition 0.000 description 5
- 239000011719 vitamin A Substances 0.000 description 5
- 229940045997 vitamin a Drugs 0.000 description 5
- 240000007185 Albizia julibrissin Species 0.000 description 4
- 235000011468 Albizia julibrissin Nutrition 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 208000010340 Sleep Deprivation Diseases 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 210000004958 brain cell Anatomy 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 210000005229 liver cell Anatomy 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- -1 triterpene compound Chemical class 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 210000004885 white matter Anatomy 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 208000034189 Sclerosis Diseases 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000033764 rhythmic process Effects 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 239000001263 FEMA 3042 Substances 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 240000001307 Myosotis scorpioides Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- IUJDSEJGGMCXSG-UHFFFAOYSA-N Thiopental Chemical compound CCCC(C)C1(CC)C(=O)NC(=S)NC1=O IUJDSEJGGMCXSG-UHFFFAOYSA-N 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 241000256856 Vespidae Species 0.000 description 2
- 230000009102 absorption Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000036524 ataraxia Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000005907 cancer growth Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 229960003654 desoxycortone Drugs 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical group [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002366 mineral element Substances 0.000 description 2
- 230000004118 muscle contraction Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229940043200 pentothal Drugs 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229940033123 tannic acid Drugs 0.000 description 2
- 235000015523 tannic acid Nutrition 0.000 description 2
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 2
- 229920002258 tannic acid Polymers 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 210000000515 tooth Anatomy 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- ZESRJSPZRDMNHY-YFWFAHHUSA-N 11-deoxycorticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 ZESRJSPZRDMNHY-YFWFAHHUSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010054196 Affect lability Diseases 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- 101710112752 Cytotoxin Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 235000002673 Dioscorea communis Nutrition 0.000 description 1
- 241000544230 Dioscorea communis Species 0.000 description 1
- 101710158332 Diuretic hormone Proteins 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000019025 Hypokalemia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 208000007093 Leukemia L1210 Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 102000001621 Mucoproteins Human genes 0.000 description 1
- 108010093825 Mucoproteins Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028817 Nausea and vomiting symptoms Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 240000004072 Panicum sumatrense Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000035753 Periorbital contusion Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 208000035755 Psychosomatic disease Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 206010038490 Renal pain Diseases 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241001147687 Staphylococcus auricularis Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 102100029677 Trehalase Human genes 0.000 description 1
- 108010087472 Trehalase Proteins 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 239000006035 Tryptophane Substances 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical compound [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002137 anti-vascular effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 229940119577 blood stop Drugs 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 208000030303 breathing problems Diseases 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 101150010415 eat-5 gene Proteins 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000018931 inflamed eyes Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000003446 memory effect Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 229940099909 multivitamin and iron Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 231100000590 oncogenic Toxicity 0.000 description 1
- 230000002246 oncogenic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000003617 peroxidasic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000010376 poriatin Substances 0.000 description 1
- BITYAPCSNKJESK-UHFFFAOYSA-N potassiosodium Chemical compound [Na].[K] BITYAPCSNKJESK-UHFFFAOYSA-N 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 208000007645 potassium deficiency Diseases 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000004799 sedative–hypnotic effect Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 239000000717 tumor promoter Substances 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 208000005494 xerophthalmia Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明属保健食品技术领域,针对现代社会的快速发展,人们睡眠问题得不到解决,提供一种用于安神、改善睡眠的百香果配方食品。由百香果、小米、合欢花、茯神、桑葚、核桃仁、葵花籽、黄花菜按一定比例制备而成。健脑、补气养血、清肺润燥、安神明目、止痛、全面神经安定作用。健脾和胃、补益虚损,和中益肾,补中益气、凉血止血、清肝泻火、和胃安眠;舒缓焦虑紧张、抑郁寡欢、神经紧张引起的头痛头晕、耳鸣咽痛、神经麻木、反应迟钝、健忘失眠、能安五脏,有较好的强身、镇静安神、改善睡眠,提高人体免疫力作用。对心神不安、忧郁失眠、健忘,食欲不振、全身无力等症均有显著食疗效果。既是改善失眠和睡眠障碍的首选食品,又是神经衰弱治疗剂。
Description
技术领域
本发明属于保健食品技术领域,具体涉及一种用于安神、改善睡眠的百香果配方食品。
背景技术
人的一生大约有三分之一的时间是在睡眠中度过的,睡眠和人们的生理和心理活动密切相关。当人们处于睡眠状态中时,可以使人们的大脑和身体得到休息、休整和恢复。良好的睡眠可以促进大脑的发育,保护中枢神经系统,增强机体的免疫机制,巩固记忆发挥大脑功能,促进机体生长、延缓衰老,有助于提高人们日常的工作和学习效率。睡眠是我们日常生活中一种重要的生理现象,睡眠跟人们的生理和心理活动有密切的关系,对人的健康和生活有着至关重要的影响。良好的睡眠可以帮助人们恢复体力和精力。
失眠是一种慢性疾病,是由中枢神经失调导致神经官能紊乱造成的,也是人类至今没有较好办法来控制的一种疾病。失眠可导致疲劳、精神状态欠佳、注意力不集中,严重影响人们的日常生活。长期的失眠还会导致抑郁症、内分泌失调、精神焦虑等。
因此失眠和睡眠障碍问题越来越受到人们的关注。但是,随着现代社会的快速发展,人们的生活节奏也逐渐加快,工作压力以及各方面的压力也越来越大,失眠问题已经成为困扰我们日常生活的常见疾病。
现代社会的快速发展,人们的生活节奏也逐渐加快,工作压力以及各方面的压力也越来越大,失眠问题已经成为困扰我们日常生活的常见疾病。睡眠不足直接导致人们思维迟缓、头脑紧张、注意力不集中、行动迟缓、厌烦、忧虑、倦怠,对工作缺乏热情,使工作主动性与工作意愿下降,从而降低工作效率。另外睡觉时间不够的人会行动迟缓,注意力不集中,反应迟钝,运动技巧更差,引起情绪的不稳定。睡眠不足的人会感到特别的疲惫辛苦,容易情绪不稳定,如果是长期下来,许多人的心理会出现问题,暴躁、易怒,缺乏自制力,造成严重的后果。失眠还会导致抵抗力下降,患病机率大。消化系统、心血管系统受心理因素影响较大,睡眠不足引起的情绪问题,会使胃液分泌减少,影响消化,发生胃部疾患。患有冠心病的病人,病情更易受情绪的影响,轻者加重病情,重者后果不堪设想,危及生命。同时癌症、心脏病、糖尿病等也会随着睡眠不足而容易导致。而且病情的加重又影响睡眠,不良的睡眠又会波及到情绪,进而形成了恶性循环的社会问题。
发明内容
本发明针对现代社会的快速发展,人们睡眠问题一直得不到很好的解决,提供一种用于安神、改善睡眠的百香果配方食品。
本发明是由以下技术方案实现的:一种用于安神、改善睡眠的百香果配方食品,由下列重量份的原料组成:百香果22~110份、小米20~100份、合欢花12~60份、茯神12~60份、桑椹8~40份、核桃仁6~30份、葵花籽6~30份、黄花菜4~20份。
优选配比为:百香果22~88份、小米20~80份、合欢花12~48份、茯神12~48份、桑椹8~32份、核桃仁6~24份、葵花籽6~24份、黄花菜4~16份。
最佳配比为:百香果88份、小米80份、合欢花48份、茯神48份、桑椹32份、核桃仁24份、葵花籽24份、黄花菜16份。
用于安神、改善睡眠的百香果配方食品的制备方法为:(1)原料处理:新鲜成熟的百香果清洗后挑选果肉进行喷雾干燥,然后置于阴凉干燥处备用;小米用文火炒制15-20min,小米炒熟后冷却干燥,然后置于阴凉干燥处备用;合欢花上锅蒸制2-4min,沥干水分,然后60℃烘干机内烘干4小时,冷却后置阴凉干燥处备用;茯神、核桃仁、脱壳葵花籽分别于60~80℃真空脱水、干燥、置阴凉干燥处备用;桑椹先用文火蒸制40-48min后置于60℃烘干机内烘干8~12小时,然后冷却干燥,待水分达到5%-10%时置于阴凉干燥处备用;黄花菜先蒸制8-12min,然后置于60℃烘干机内烘干8~12小时,然后冷却干燥,待水分达到5%-10%时置于阴凉干燥处备用;(2)混合:将步骤(1)处理好的百香果、小米、合欢花、茯神、桑椹、核桃仁、葵花籽、黄花菜按比例混合后于-30~-24℃进行低温粉碎至300目细粉,搅拌均匀包装即可。所制备的粉剂分装为80g/袋。该粉剂的保质期为12个月。
本发明所述用于安神、改善睡眠的百香果配方食品中:
百香果:味甘、酸,性平。归心、大肠经。功能主治:清肺润燥;安神止痛;和血止痢。主咳嗽、咽干、声嘶、大便秘结、失眠、痛经、关节痛、痢疾。百香果果实含有人体所需17种氨基酸、多种维生素和类胡萝卜素,其中包括非常丰富的维生素C,每100克果汁中就含有维生素C为34.6毫克,还富含维生素A、B1、B2等。另外还含有丰富的钙、磷、铁和多种氨基酸等物质及微量元素。可溶性固形物占5%-16%,总酸量为3.8%-4%,甜酸适中,被誉为“Vc之王”、“补钙新星”、“补铁新星”等。果汁营养物质丰富,香味浓郁独特,据报道至少含有160多种香味物质,被誉为“天然浓缩果汁”、“果汁之王”,是世界上已知的最芳香的水果之一,非常适宜与其它果汁混合,能强烈影响混合果汁饮料的滋味,风味极佳。现代研究表明。百香果果汁中含有大量对人体有益的Na 、K、Ca 、Mg 、Zn 、F e 、Ge 等矿物元素,营养价值极高的纯天然保健水果。
百香果的功能作用:古方中医食疗记载,百香果对中枢神经系统具有复杂的作用,具有全面神经安定作用。能够舒缓焦虑紧张、抑郁寡欢、神经紧张引起的头痛、果汁具有生津止渴、提神醒脑、帮助消化、化痰止咳、治肾亏和滋补强身的功能。百香果含有丰富的抗氧化剂、纤维、矿物质和维生素等众多基本营养,都是胎儿生长发育所需要的。因此怀孕期间食用百香果可以确保宝宝健康。提高免疫力:百香果有增强免疫力的特性,含有大量维生素C、β-隐黄素和α-胡萝卜素。这些抗氧化剂可以中和自由基的活性,防止细胞损坏,减少氧化压力和保证妊娠健康。确保骨骼健康:百香果含有丰富的矿物质,如磷,铁,镁,铜等,多摄取可以增加矿物质骨骼密度,使骨骼强健。食用百香果也可以预防或减少骨质疏松症和关节疼痛。减少失眠焦躁:百香果含有药用生物碱,提供了一个镇静的功用。因此,怀孕期间食用百香果可以有效减少躁动、焦虑和失眠。减少呼吸问题:食用百香果的提取物可以减轻气喘、咳嗽和哮喘的症状。促进消化健康:百香果含有丰富的纤维,食用1颗就可以提供人体98%必须营养物质的日常所需。经常食用百香果可以提高消化、改善排便、防止便秘。调节血压:百香果含有丰富的钾,钾为血管放松剂,放松血管,改善血液流动。因此,食用百香果可以帮助控制血压。改善血液循环:百香果的含铁量很高,有助于增加血红素的生产。良好的红血球数量可以扩张血管,使含氧的血液在身体中到处流动,有助于提高各器官的功能。皮肤眼睛健康:百香果中的维生素A可以防止白内障、夜盲症和其他眼睛问题;也可以提高皮肤的健康。
小米:味甘、咸、性凉;入肾、脾、胃经;具有健脾和胃、补益虚损,和中益肾,除热,解毒之功效;主治脾胃虚热、反胃呕吐、消渴、泄泻。
小米是五谷之首,常食能补脾益胃。对脾虚体弱的人而言,可谓是进补的上品,可补中益气、延年益寿。除烦去燥。对消除女性更年期综合征、自汗盗汗以及烦躁情绪有食疗作用。小米的营养价值很高,每100克小米含蛋白质9.7克,比大米高,脂肪1.7克,碳水化合物76.1克,都不低于稻、麦。一般粮食中不含有的胡萝卜素,小米每100克含量达0.12毫克,维生素B1的含量位居所有粮食之首。小米的营养优势:含有丰富的脂肪,为大米7.8倍,且主要为不饱和脂肪酸;含有大量的维生素E,为大米的4.8倍;膳食纤维含量丰富,为大米的4倍;含钾高含钠低,钾钠比大米为9:1,而小米为66:1,经常吃些小米,对高血压患者有益;含铁量高,为大米的4.8倍;含磷也丰富,为大米的2.3倍。这就是小米能补血、健脑的原因。除含有丰富的营养成分外,小米中色氨酸含量为谷类之首,色氨酸有调节睡眠的作用。中医认为,小米味甘咸,有清热解渴、健胃除湿、和胃安眠等功效。用小米煮粥,睡前服用,易使人安然入睡。
合欢花:味甘,性平,舒郁、理气、安神、活络、养血、滋阴肾、清心明目。合欢花含有合欢甙,鞣质,解郁安神,滋阴补阳,理气开胃,活络止痛,用于心神不安、忧郁失眠。治郁结胸闷,失眠,健忘,风火眼,能安五脏,和心志,悦颜色,有较好的强身、镇静、安神、美容的作用,也是治疗神经衰弱的佳品。也具有清热解暑,养颜祛斑解酒等功效。
合欢花水煎剂的镇静催眠作用:历代文献对合欢花镇静、催眠作用的记载较多。合欢花的水煎剂22.5g/Kg浓度对小白鼠均有极显著的镇静、催眠作用。
合欢花总黄酮提取液清除自由基的作用:有研究发现合欢花中总黄酮提取液对·OH自由基有一定的清除作用,当合欢花总黄酮浓度达到0.06mg.mL-1时,对·OH自由基清除率为62.81%。
茯神:性平,味甘、淡;归心、脾经;宁心、安神、利水。用于心虚惊悸,健忘,失眠,惊痫,小便不利。
茯神除含营养素,如碳水化合物、蛋白质外,还含有多种生物活性成分。目前已分离鉴定的茯神的特征性化合物有50余种,包括多糖、三萜、脂肪酸、甾醇、酶等。
茯神始载于《神农本草经》,《本草纲目》、《金匮要略》等中医药典中均有记载,对人体安全无毒无副作用,现代营养学研究表明茯神与茯苓同样具有显著的抗肿瘤、健脾胃、利水消肿、镇定安神、增强免疫及抑菌等作用,但茯神长于镇静安神。
抗肿瘤作用:试验研究表明,茯神的抗肿瘤作用主要是通过增强机体免疫功能来抑制肿瘤生长。从茯神中提取的被称为茯苓素(po riatin)的三萜类化合物的混合物在体外对小鼠白血病L1210 细胞的DNA 合成有明显的不可逆抑制作用,可以显著抑制L1210 细胞核的运转。茯苓素对艾氏腹水癌、S180肉瘤以及小鼠Lewis肺癌的转移也有一定抑制作用。另外,茯苓素对抗癌药有增效作用,也可以增强巨噬细胞产生肿瘤坏死因子的能力。
茯神具有镇静作用。茯神是临床常用的安神药物,药理研究和临床用药表明,茯神可以延长睡眠时间,与戊巴比妥钠等有协同作用,对多数失眠、入睡困难和睡眠易醒的人都有较好的疗效。茯神煎剂腹腔注射,能明显降低小鼠的自发活动,并能对抗咖啡因所致的小鼠过度兴奋。茯神煎剂小鼠腹腔注射对戊巴比妥钠的麻醉作用有明显的协同作用。并可增强硫喷妥钠对小鼠中枢抑制作用,使麻醉时间显著延长。茯神提取成分羧甲基多糖也有较好的镇静作用,羧甲基多糖100 mg/kg/日,腹腔注射12 日,可对抗60Co -γ射线对小鼠末梢白细胞的抑制作用,可使小鼠肝匀浆细胞色素P450 含量减少,增强硫喷妥钠对小鼠中枢抑制作用,使麻醉时间显著延长。
利水消肿作用:茯神的利水作用与体液的利尿激素样调节机制以及肾的生理作用关系密切。茯苓素是利水消肿的主要成分,它能激活细胞膜上与利尿有关的ATP酶。以25%的茯神醇浸剂对正常家兔腹腔注射,表现利尿作用;用茯神灰分与茯神醇浸剂对家兔进行慢性实验,证明醇浸剂也有利尿作用,而灰分无此作用,说明利尿作用是由钾盐以外的其他成分所致。用切除肾上腺的大鼠进行实验,30%茯神煎剂与去氧皮质酮一起使用比单一的去氧皮质酮尿量增多,尿中钾和钠的排除量增多,从而说明茯神不具有抗去氧皮质酮作用,而与影响肾小管对钠离子的重吸收有关。
茯苓素可改善老年人的免疫功能,增强体质、保护骨髓,预防和减轻放化疗的毒副反应,达到扶正固本、健脾补中的作用。改性的茯苓多糖衍生物具有增强免疫功能的作用,既可增强细胞免疫,又可增强体液免疫。
从茯神的甲醇提取液中分得三萜化合物,其可以抑制TPA引起的鼠耳肿;在鼠皮肤致癌过程中几种抗炎物质有抑制肿瘤促进剂作用,抗炎作用可能在抗肿瘤促进机理中起重要作用,研究证明TPA引起的炎症模型检测对鼠耳肿的抑制活性。因为对TPA 引起炎症的抑制潜伏期可以平行地检测对肿瘤促进作用的抑制活性,使其成为天然的潜在抗炎剂,所以茯神具有天然抗炎作用。另外茯神煎剂对金黄色葡萄球菌(Staphy lococcus auricularis)、结核杆菌(My cobacteriumtuberculo sis)和变形杆菌(Proteus vulg aris)等有抑制作用。
保肝作用:茯神对四氯化碳所致大鼠肝损伤有明显的保护作用,使谷丙转氨酶活性明显降低,防止肝细胞坏死。茯神抗肝细胞坏死的效果显著,能使肝细胞肿胀显著减退,肝脏重量明显增加,并加速肝细胞再生,达到保肝降酶的作用。
桑椹:性甘、酸,寒;归心、肝、肾经。桑椹含有丰富的活性蛋白、维生素、氨基酸、胡萝卜素、矿物质等成分,具有补益肝肾,滋阴养血,对乌发有特效,息风,清肝明目,解酒,改善睡眠,提高人体免疫力,延缓衰老,美容养颜,降低血脂,防癌。桑椹粉富含蛋白质,多种人体必需的氨基酸,易被人体吸收的果糖和多种维生素及铁、钙、锌等矿物元素、硒等微量元素及胡萝卜素、纤维素等。具有多种功效,被医学界誉为“二十一世纪的最佳保健果品”。
桑椹的作用:补充营养:桑椹中含有大量水分、碳水化合物、多种维生素、胡萝卜素及人体必需的微量元素等,能有效地扩充人体的血容量,且补而不腻,适宜于高血压、妇女病患者食疗;健脾胃助消化:桑椹中含有鞣酸、脂肪酸、苹果酸等营养物质,能促进脂肪、蛋白质及淀粉的消化,故有健脾胃、助消化之功效,可用于治疗因消化不良而导致的腹泻;乌发美容:桑椹中除含有大量人体所需营养物质外,还含有乌发素,能使头发变得黑而亮泽,故可用来美容;防血管硬化:桑椹中含有鞣酸、苹果酸、维生素C和脂肪酸等。其中所含的脂肪主要为亚油酸、油酸、软脂酸、硬脂酸、亚麻酸等。此外,桑椹中含有丰富的白黎芦醇。白黎芦醇是一种有效的抗氧化剂,能抑制低密度脂蛋白的脂质过氧化反应,防止低密度脂蛋白氧化产生的细胞毒素,从而保护细胞的脂质过氧化。白黎芦醇还能降低血小板聚集,从而预防动脉硬化;防癌抗癌:桑椹中含有大量芦丁,现代医学证明芦丁可以阻止结肠癌的形成。芦丁可凉血止血、清肝泻火,具抗炎、抗病毒作用。故常吃桑椹还有助于防治脑出血、高血压、视网膜出血、慢性支气管炎等;补肝益肾:桑椹主入肝肾,善滋阴养血、生津润燥,适于肝肾阴血不足及津亏消渴、肠燥等症。
核桃仁:味甘,性温、平、无毒。入食之体健、润肤黑发。补肺敛肺、润肠通便、补气养血。有健肾、补血、润肺、益胃之功效,对肾亏腰痛,肺虚久咳、气喘、大便秘结,病后虚弱以及头晕、失眠、食欲不振、全身无力等症均有一定疗效。核桃仁含有丰富的营养素,每百克含蛋白质15~20克,脂肪60~70克,碳水化合物10克;并含有人体必需的钙、磷、铁等多种微量元素和矿物质,以及胡萝卜素、核黄素等多种维生素。核桃中所含脂肪的主要成分是亚油酸甘油脂,食后不但不会使胆固醇升高,还能减少肠道对胆固醇的吸收,因此,可作为高血压、动脉硬化患者的滋补品。此外,这些油脂还可供给大脑基质的需要。核桃中所含的微量元素锌和锰是脑垂体的重要成分,常食有益于脑的营养补充,有健脑益智作用。核桃仁不仅是最好的健脑食物,又是神经衰弱的治疗剂。患有头晕、失眠、心悸、健忘、食欲不振、腰膝酸软、全身无力等症状的老年人,每天早晚各吃1~2个核桃仁,即可起到滋补治疗作用。核桃仁还对其它病症具有较高的医疗效果,如它具有补气养血、润燥化痰、温肺润肠、散肿消毒等功能。近年来的科学研究还证明,核桃树枝对肿瘤有改善症状的作用,以鲜核桃树枝和鸡蛋加水同煮,然后吃蛋,可用于预防子宫颈癌及各种癌症。科学家们发现,每100克核桃肉中含有20.97个单位的抗氧化物质,它比柑桔高出20倍,菠菜的抗氧化成份为0.98个单位,胡萝卜为0.04个单位,西红柿为0.31个单位。
葵花籽:性平味甘,归大肠经;补虚损.降血脂,抗癌;治疗神经衰弱、失眠、高血压、动脉硬化、高血脂、癌症、蛲虫。
葵花籽含脂肪可达50%左右,其中主要为不饱和脂肪,而且不含胆固醇;亚油酸含量可达70%,有助于降低人体的血液胆固醇水平,有益于保护心血管健康。丰富的铁、锌、钾,镁等微量元素使葵花籽具有预防贫血等疾病的作用。葵花籽是维生素B1和维生素E的良好来源。对安定情绪、防止细胞衰老,预防成人疾病都有好处。它还具有治疗失眠、增强记忆力的作用。对癌症、高血压和神经衰弱有一定的预防功效。除富含不饱和脂肪酸外,葵花籽中还含有多种维生素、叶酸、铁、钾、锌等人体必需的营养成分。葵花籽当中有大量的食用纤维,每7克的葵花籽当中就含有1克,比苹果的食用纤维含量比例高得多。在葵花籽的蛋白质当中含有精氨酸。精氨酸是制造精液不可缺少的成分。因此,处在生育期的男人,每天食用一些葵花籽对身体是非常有好处的。
葵花子种仁的蛋白质含量为30%,可与大豆、瘦肉、鸡蛋、牛奶相比;各类糖的含量为12%;脂肪的含量优于动物脂肪和植物类油脂,因为它含有的不饱和脂肪酸,其中亚油酸占55%;钾、钙、磷、铁、镁也十分丰富,尤其是钾的含量较高,每100克含钾量达920毫克;还含有维生素A、B1、B2;每15克就含维生素E31毫克;最贵重的是葵花子中的油,种仁含油率为50%-55%,已成为仅次于大豆位居第二的油料作物。另外,葵花子对癌症、高血压、心脏病、缺铁性贫血等也有一定的疗效。采用低温榨油先进技术,将葵花子加工成蛋白粉,可供食用。这种蛋白粉色泽白、口感好、营养高、易吸收。用这种蛋白粉可制成滋养面包、人造肉、香肠、罐头等保健食品。
黄花菜:性平、味甘、微苦,归肝、脾、肾经;有清热利尿,解毒消肿,止血除烦,宽胸膈,养血平肝,利水通乳,利咽宽胸,清利湿热,发奶等功效;主治眩晕耳鸣、心悸烦闷、小便赤涩、水肿、痔疮便血等病症。表3为黄花菜中营养成分含量表。
黄花菜的药用价值很高,它的花、叶、块根均可入药。它含有γ-羟基谷氨酸、琥珀酸、β-谷甾醇、天门冬素、秋水仙碱、海藻糖酶等成分。黄花菜的药用功效早在《本草纲目》上就有记载:“味甘而气微凉,祛湿利水,除热通淋,止渴消烦,开胸宽膈令人心平气和,免于忧郁。”其性平味甘,具有很好的利水凉血、安神明目、健脑、抗衰老功能,并能显著降低血清胆固醇含量,所以对于脑力劳动者及高血压患者有良好的保健作用。黄花菜对于正处在生长发育阶段的青少年及孕妇、产妇、病患者来说,经常食用,同样对健身益智十分有益,滋补作用很好。随着人们生活节奏的加快和竞争的激烈,各种心身疾病与日剧增,常食黄花菜,可愉悦情志,宣畅愁怀,能防止神经麻木、反应迟钝、健忘失眠、头晕耳鸣等。还可滋润皮肤,增强皮肤的韧性和弹力,保护表皮与真皮组织,加速皮肤血液循环,使皮肤白皙饱满,滑润柔软。还能降低血脂,防止动脉硬化。
黄花菜的营养成分对人体健康特别是胎儿发育十分有益,因此可作为孕妇的保健食品。黄花菜具有较佳的健脑抗衰功能,有“健脑菜”之称,精神过度疲劳的现代人应经常食用。能预防中老年疾病和延缓机体衰老。它所含的冬碱等成分有止血消炎、利尿安神、健胃等功效。
黄花菜入药始见于《日华子本草》,中医认为其味甘性平,能养血平肝,安神明目、利尿消肿,可治头晕、耳鸣、咽痛、吐血、心悸、腰痛、乳痈等疾患。《云南中草药》言其“养血,补虚,清热”。《昆明民间常用草药》言其“补虚下奶,平肝,利湿,消肿止血”。中医本草书上称其能“开胸宽膈,令人心气平和,无有忧郁”,“利胸膈、安五脏,令人好欢无忧”。
现代医学研究发现,黄花菜含有丰富的卵磷脂,这种物质是人体许多细胞,特别是大脑细胞的组成成分,对增强和改善大脑功能有重要作用。研究还表明,黄花菜能显著降低血清胆固醇的含量,有利于高血压患者的康复,可作为高血压患者的保健蔬菜。黄花菜所含的有效成分能抑制癌细胞的生长,丰富的粗纤维能促进大便的排泄,因此可作为防治肠道癌瘤的食品。黄花菜还可以用来治疗神经衰弱。从中医理论上说,忧愁郁闷常是因为身体虚弱引起的,金针菜含有丰富的营养,常吃之后,虚弱的体质能逐渐转为强壮,身体强壮了,人自然无忧无虑,这就是古书上所说,使人“心气平和”、“安五脏”的意思。而从现代医学观点来看,金针菜能治疗神经衰弱,使人忘忧安眠,主要就是因其含有钙、磷成分的原因。
每100克干黄花菜中含蛋白质10.1克,脂肪1.6克,碳水化合物62.6克,比西红柿和大白菜高10倍。碳水化合物的含量和所含的热量与大米相似,维生素A的含量比胡萝卜高1.52~2倍。此外,粗纤维、磷、钙、铁及矿物质的含量也很丰富,有较好的健脑,抗衰老功效,是因其含有丰富的卵磷脂,这种物质是机体中许多细胞,特别是大脑细胞的组成成分,对增强和改善大脑功能有重要作用,同时能清除动脉内的沉积物,对注意力不集中、记忆力减退、脑动脉阻塞等症状有特殊疗效,故人们称之为“健脑菜”。另据研究表明,黄花菜能显著降低血清胆固醇的含量,有利于高血压患者的康复,可作为高血压患者的保健蔬菜。黄花菜中还含有效成分能抑制癌细胞的生长,丰富的粗纤维能促进大便的排泄,因此可作为防治肠道癌瘤的食品。
上述各组份混合后,利用不同植物所含特殊功能的成分和全部配方的综合协调作用,相互促进、相互作用提高食用效果。利用相互间营养成分、营养素量的互补及各自具有的独特的天然保健功能来满足人群对营养成分、营养素和健康功能的需求。
本发明所含的总黄酮类化合物能防治心脑血管系统的疾病和呼吸系统的疾病,具有抗炎抑菌、降血糖、抗氧化、抗辐射、抗癌的作用。近年来大量研究显示,黄酮类化合物在肺癌、结肠癌、乳腺癌、前列腺癌、胰腺癌等的治疗和预防中均发挥重要作用,其抗癌机制涉及阻滞癌细胞增殖、诱导肿瘤细胞凋亡、抗氧化活性、抑制新生血管形成等各方面。
本发明所含的蛋白质具有修补细胞与建造组织。构成体内所有的细胞和组织;维持细胞的正常功能与新陈代谢;形成酵素系统,维持正常的消化机能;制造血液的运送物质,维持身体的渗透压。参与酶的催化、荷尔蒙调节、氧气运载、肌肉收缩、身体免疫、身体支架和体液中。
本发明所含的脂肪是构成身体细胞、组织和生物活性的重要物质成分之一,脑神经、肝脏、肾脏等重要器官中含有很多脂肪。皮下脂肪组织有保持体温的作用;脂肪可作为身体备用“燃料”;具有调节生理机能、保护内脏器官、滋润皮肤、防震和溶解营养素的作用。有些不溶于水而只溶于脂类的维生素,只有在脂肪存在时才能被人体吸收利用。长期缺乏脂肪性成分,就容易引起人体维生素A、D的缺乏症,以致出现皮肤干燥,头发枯燥、脱落、及患夜盲症、干眼症等疾病。
本发明所含的钙是骨骼、牙齿及软组织的重要成分。要保持骨骼和牙齿的健康、神经的传输、肌肉收缩、血液凝固、荷尔蒙平衡都处在一个好的状态,钙不可缺乏。钙能帮助保护心脏和皮肤,减轻肌肉劳累和疼痛,保持体液酸碱平衡,减少肌肉痉挛。本发明所含的碳水化合物,亦称糖类,是人体热能最主要的来源。是构成机体的成分并在多种生命过程中起重要作用。如碳水化合物与脂类形成的糖脂是组成细胞膜与神经组织的成分,粘多糖与蛋白质合成的粘蛋白是构成结缔组织的基础,糖类与蛋白质结合成糖蛋白可构成抗体、某些酶和激素等具有重要生物活性的物质。人体的大脑和红细胞必须依靠血糖供给能量,因此维持神经系统和红细胞的正常功能也需要糖。糖类与脂肪及蛋白质代谢也有密切的关系。糖类具有节省蛋白质的作用。当蛋白质进入机体后,使组织中游离氨基酸浓度增加,该氨基酸合成为机体蛋白质是耗能过程,如同时摄入糖类补充能量,可节省一部分氨基酸,有利蛋白质合成。食物纤维是一种不能被人体消化酶分解的糖类,虽不能被吸收,但能吸收水分,使粪便变软,体积增大,从而促进肠蠕动,有助排便。本发明所含的碳水化合物是供给能量来源的重要物质,是构成细胞和组织不可缺少的物质,具有维持脑细胞的正常功能,合成生物大分子物质的前体,如嘌呤、嘧啶、胆固醇等。
本发明所含的钾,钾是钠的平衡剂。缺钾、钠和水分就会进入细胞,造成水肿,破坏细胞,使肌肉和结缔组织受到扩张和损害,也是肥胖的因素之一。钾可增进体内多种酵素的活动量,对肌肉的伸展发生很大的作用。没有钾食物中的葡萄糖不能转化成精力,也不能转化成肝糖储存起来,往往造成部分肢体麻痹。
本发明所含的维生素是维持人体生命活动必须的一类有机物质,也是保持人体健康的重要活性物质。是人和动物营养、生长所必需的某些少量有机化合物,对机体的新陈代谢、生长、发育、健康有极重要作用。如果长期缺乏某种维生素,就会引起生理机能障碍而发生某种疾病。
本发明所含的锌是参与人体内核酸蛋白质的合成,是肾上腺皮质激素的固有成分,为人体生长发育的重要物质。
本发明的有益效果如下:结合中国自古的食疗理论和营养平衡理论,营养积累理论,以现代科学研究结果为依据,运用中医阴阳平衡与“君、臣、佐、使”组方理论配伍,性平中和,食疗效果明显,吸收好,见效快。纯天然植物制剂,原料购买方便、食用安全、副作用小,具有很多的生理药理功能,有养生的功效,是中老年人、女性的天然营养保健品,用这些原料来改善睡眠更容易使人们接受。本发明科学、技术先进、工艺简单、容易实现规范化工厂生产;营养丰富,食用方便,弥补了日常饮食品种单一的不足,符合现代人身体健康的需要,长期服用,慢慢调理,必将收到良好的效果,具有食用与促进健康两种功能。
本发明所用的各组分原料来源广泛,价格低廉。可充分利用丰富的自然资源进行综合加工,符合农业产业政策,符合我国特色农业现代化发展道路的要求;符合农业和农村经济发展进入新阶段的要求;符合城乡居民生活水平不断提高的要求;符合农民渴望增加收入的要求,是留利给农民、留就业岗位给农民、留税收给产区的一个很好的产业,是延长农业产业链条、构建现代农业、将小生产与大市场对接的有效途径,是实现小规模农业生产与现代农业大生产对接的必由之路,也是破解农产品卖难、农业增效难和农民增收难的战略举措。
总之本发明具有入食之健脑、安神明目、补气养血、清肺润燥、安神止痛、对中枢神经系统具有全面神经安定的功能。可健脾和胃、补益虚损,和中益肾,补中益气、凉血止血、清肝泻火、和胃安眠等功效。能够舒缓焦虑紧张、抑郁寡欢、神经紧张引起的头痛、头晕、耳鸣、咽痛、神经麻木、反应迟钝、健忘失眠、能安五脏之功效,有较好的强身、镇静、安神、改善睡眠,提高人体免疫力作用。用于心神不安、忧郁失眠、健忘,食欲不振、全身无力等症均有一定疗效。不仅是改善失眠和睡眠障碍的首选食品,又是神经衰弱的治疗剂。具有食用与促进健康两种功能。
本发明所述用于安神、改善睡眠的百香果配方食品用于临床的情况如下:对2015年5月年至2017年7月期间共186例的中老年人,其中男91人,女95人使用本发明,每日1次、每次1(80克)/袋,晚上睡前开水冲泡饮用,坚持食用一个疗程8个月观察疗效,疗效见表1。
表1
典型病例:
1.张某,女,62岁,患二型糖尿病30年,头晕、失眠、疲乏无力、情绪低落,心情很糟糕、晚上睡不着觉、养成了白天上午睡觉的习惯。2016年3月开始食用本发明食品,每晚睡前开水冲泡1袋,服用一年半后,头晕现象减少、睡眠好转,有时一晚上醒一次,有时可一觉睡到天亮,心情好了,家庭和睦,现在还坚持食用本发明所述食品。
2.刘某,男,35岁,经常失眠、睡眠不足,心情忧虑焦急,经常感冒、消化不良、脾胃虚弱、面色萎黄,眼圈发黑、气色不好已有8年之久。2016年5月开始食用本发明食品,每晚睡前开水冲泡1袋(80克),食用一年后,各种症状减轻,睡眠好了、能正常吃饭了,面色红润,感冒也少了、恢复到正常人的光泽,现在还坚持食用本发明食品。
3.胡某,男,45岁,失眠、经常睡不着觉,上班时经常头昏脑胀、注意力不集中,经常出现头痛的现象,眼睛经常流泪、眼睛红肿、心情忧虑焦急,白天易瞌睡,抑郁寡欢、神经紧张患此症状已有12年,2016年6月开始食用本发明食品,食用5个月,每晚睡前开水冲泡1袋(80克),各种症状开始好转,服用一年后,头脑清晰、身体有精神了、工作精力充沛,人也显得年轻了。
4.范某,女,16岁,中学生,经常睡不着觉,晚上做梦多、经常在睡梦中惊醒,上课时经常头昏脑胀、注意力不集中,经常出现打瞌睡,学习成绩不好,在同学面前抬不起头,已有3年的病史。2016年12月开始食用,每晚睡前开水冲泡1袋,食用2个月,各种症状明显改善,学习成绩逐渐提高,心情好了,笑声有了。现在还坚持食用本发明食品。
5.暴某,女,62岁,失眠、抑郁寡欢、神经紧张、精神不振、懒洋洋的身心、无精打采、不愿意和同仁交流。已有18年的病史。2016年3月,开始食用本发明食品,食用二年多,睡眠好了,头也不晕了,吃饭香了。还能经常和老年朋友打扑克,跳健身操。现在坚持食用本发明食品。
具体实施方式
以下结合实施例对本发明做进一步详细描述。
实施例1:一种用于安神、改善睡眠的百香果配方食品,由下列重量的原料组成:百香果22g、小米20g、合欢花12g、茯神12g、桑葚12g、核桃仁6g、葵花籽6g、黄花菜4g。制备方法为:(1)原料处理:新鲜成熟的百香果清洗后挑选果肉进行喷雾干燥,然后置于阴凉干燥处备用;小米用文火炒制15min,小米炒熟后冷却干燥,然后置于阴凉干燥处备用;合欢花上锅蒸制2min,沥干水分,然后60℃烘干机内烘干4小时,冷却后置阴凉干燥处备用;茯神、核桃仁、脱壳葵花籽分别于60℃真空脱水、干燥、置阴凉干燥处备用;桑椹先用文火蒸制40min后置于60℃烘干机内烘干10小时,然后冷却干燥,待水分达到5%-10%时置于阴凉干燥处备用;黄花菜先蒸制8min,然后置于60℃烘干机内烘干12小时,然后冷却干燥,待水分达到5%-10%时置于阴凉干燥处备用;(2)混合:将步骤(1)处理好的百香果、小米、合欢花、茯神、桑椹、核桃仁、葵花籽、黄花菜按比例混合后于-30℃进行低温粉碎至300目细粉,搅拌均匀包装即可。所制备的粉剂分装为80g/袋。保质期为12个月。本实施例所制备的食品,同样采用上述的服用方法进行临床试验,总有效率达95%。
实施例2:一种用于安神、改善睡眠的百香果配方食品,由下列重量的原料组成:百香果44g、小米40g、合欢花24g、茯神24g、桑葚12g、核桃仁12g、葵花籽12g、黄花菜8g。
制备方法为:(1)原料处理:新鲜成熟的百香果清洗后挑选果肉进行喷雾干燥,然后置于阴凉干燥处备用;小米用文火炒制18min,小米炒熟后冷却干燥,然后置于阴凉干燥处备用;合欢花上锅蒸制3min,沥干水分,然后60℃烘干机内烘干4小时,冷却后置阴凉干燥处备用;茯神、核桃仁、脱壳葵花籽分别于70℃真空脱水、干燥、置阴凉干燥处备用;桑椹先用文火蒸制45min后置于60℃烘干机内烘干8小时,然后冷却干燥,待水分达到5%-10%时置于阴凉干燥处备用;黄花菜先蒸制10min,然后置于60℃烘干机内烘干10小时,然后冷却干燥,待水分达到5%-10%时置于阴凉干燥处备用;(2)混合:将步骤(1)处理好的百香果、小米、合欢花、茯神、桑椹、核桃仁、葵花籽、黄花菜按比例混合后于-28℃进行低温粉碎至300目细粉,搅拌均匀包装即可。所制备的粉剂分装为80g/袋。保质期为12个月。本实施例所制备的食品,同样采用上述的服用方法进行临床试验,总有效率达95%。
实施例3:一种用于安神、改善睡眠的百香果配方食品。是由下列重量的原料组成:百香果88g、小米80g、合欢花48g、茯神48g、桑椹32g、核桃仁24g、葵花籽24g、黄花菜16g。制备方法为:(1)原料处理:新鲜成熟的百香果清洗后挑选果肉进行喷雾干燥,然后置于阴凉干燥处备用;小米用文火炒制20min,小米炒熟后冷却干燥,然后置于阴凉干燥处备用;合欢花上锅蒸制4min,沥干水分,然后60℃烘干机内烘干4小时,冷却后置阴凉干燥处备用;茯神、核桃仁、脱壳葵花籽分别于80℃真空脱水、干燥、置阴凉干燥处备用;桑椹先用文火蒸制48min后置于60℃烘干机内烘干12小时,然后冷却干燥,待水分达到5%-10%时置于阴凉干燥处备用;黄花菜先蒸制12min,然后置于60℃烘干机内烘干8小时,然后冷却干燥,待水分达到5%-10%时置于阴凉干燥处备用;(2)混合:将步骤(1)处理好的百香果、小米、合欢花、茯神、桑椹、核桃仁、葵花籽、黄花菜按比例混合后于-24℃进行低温粉碎至300目细粉,搅拌均匀包装即可。所制备的粉剂分装为80g/袋。保质期为12个月。本实施例所制备的食品,同样采用上述的服用方法进行临床试验,总有效率达98%。
实施例4:一种用于安神、改善睡眠的百香果配方食品,由下列重量的原料组成:百香果100g、小米90g、合欢花52g、茯神50g、桑葚35g、核桃仁26g、葵花籽26g、黄花菜18g。制备方法同实施例1所述制备方法。本实施例所制备的食品,同样采用上述的服用方法进行临床试验,总有效率达97%。
实施例5:一种用于安神、改善睡眠的百香果配方食品,由下列重量的原料组成:百香果22g、小米60g、合欢花60g、茯神58g、桑葚8g、核桃仁12g、葵花籽20g、黄花菜20g。制备方法同实施例2所述制备方法,本实施例所制备的食品,同样采用上述的服用方法进行临床试验,总有效率达94%。
实施例6:一种用于安神、改善睡眠的百香果配方食品,由下列重量的原料组成:百香果110g、小米100g、合欢花60g、茯神60g、桑葚40g、核桃仁30g、葵花籽30g、黄花菜20g。制备方法同实施例3所述制备方法,本实施例所制备的食品,同样采用上述的服用方法进行临床试验,总有效率达96%。
实施例7:一种用于安神、改善睡眠的百香果配方食品,由下列重量的原料组成:百香果110g、小米20g、合欢花48g、茯神24g、桑椹40g、核桃仁24g、葵花籽6g、黄花菜4g。制备方法同实施例2所述制备方法,本实施例所制备的食品,同样采用上述的服用方法进行临床试验,总有效率达96.5%。
实施例8:一种用于安神、改善睡眠的百香果配方食品,由下列重量的原料组成:百香果66g、小米60g、合欢花36g、茯神36g、桑葚36g、核桃仁18g、葵花籽18g、黄花菜12g。制备方法同实施例2所述制备方法,本实施例所制备的食品,同样采用上述的服用方法进行临床试验,总有效率达97.8%。
Claims (5)
1.一种用于安神、改善睡眠的百香果配方食品,其特征在于:由下列重量份的原料组成:百香果22~110份、小米20~100份、合欢花12~60份、茯神12~60份、桑椹8~40份、核桃仁6~30份、葵花籽6~30份、黄花菜4~20份。
2.根据权利要求1所述的一种用于安神、改善睡眠的百香果配方食品,其特征在于:由下列重量份的原料组成:百香果22~88份、小米20~80份、合欢花12~48份、茯神12~48份、桑椹8~32份、核桃仁6~24份、葵花籽6~24份、黄花菜4~16份。
3.根据权利要求2所述的一种用于安神、改善睡眠的百香果配方食品,其特征在于:由下列重量份的原料组成:百香果88份、小米80份、合欢花48份、茯神48份、桑椹32份、核桃仁24份、葵花籽24份、黄花菜16份。
4.制备权利要求1或2或3所述的一种用于安神、改善睡眠的百香果配方食品的方法,其特征在于:具体步骤为:(1)原料处理:新鲜成熟的百香果清洗后挑选果肉进行喷雾干燥,然后置于阴凉干燥处备用;小米用文火炒制15-20min,小米炒熟后冷却干燥,然后置于阴凉干燥处备用;合欢花上锅蒸制2-4min,沥干水分,然后60℃烘干机内烘干4小时,冷却后置阴凉干燥处备用;茯神、核桃仁、脱壳葵花籽分别于60~80℃真空脱水、干燥、置阴凉干燥处备用;桑椹先用文火蒸制40-48min后置于60℃烘干机内烘干8~12小时,然后冷却干燥,待水分达到5%-10%时置于阴凉干燥处备用;黄花菜先蒸制8-12min,然后置于60℃烘干机内烘干8~12小时,然后冷却干燥,待水分达到5%-10%时置于阴凉干燥处备用;(2)混合:将步骤(1)处理好的百香果、小米、合欢花、茯神、桑椹、核桃仁、葵花籽、黄花菜按比例混合后于-30~-24℃进行低温粉碎至300目细粉,搅拌均匀包装即可。
5.根据权利要求4所述的制备用于安神、改善睡眠的百香果配方食品的方法,其特征在于:所制备的粉剂分装为80g/袋。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710450308.XA CN107259530A (zh) | 2017-06-15 | 2017-06-15 | 一种用于安神、改善睡眠的百香果配方食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710450308.XA CN107259530A (zh) | 2017-06-15 | 2017-06-15 | 一种用于安神、改善睡眠的百香果配方食品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107259530A true CN107259530A (zh) | 2017-10-20 |
Family
ID=60067687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710450308.XA Pending CN107259530A (zh) | 2017-06-15 | 2017-06-15 | 一种用于安神、改善睡眠的百香果配方食品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107259530A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020153908A3 (en) * | 2019-01-23 | 2020-09-17 | Agency For Science, Technology And Research (A*Star) | Pre-natal beta-cryptoxanthin benefits children |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102150831A (zh) * | 2010-12-03 | 2011-08-17 | 郑延明 | 改善睡眠的无花果山药天然果珍及其制备方法 |
CN103463625A (zh) * | 2013-09-22 | 2013-12-25 | 山西康禾农业有限责任公司 | 养心补血营养制剂 |
CN103609958A (zh) * | 2013-11-30 | 2014-03-05 | 大连润扬科技发展有限公司 | 一种补脑营养保健粥品 |
CN103704568A (zh) * | 2013-12-07 | 2014-04-09 | 山西康禾农业有限责任公司 | 临床膳食食品 |
CN105495614A (zh) * | 2015-12-25 | 2016-04-20 | 梁燕妮 | 治疗失眠的速食粉及其制备方法 |
CN106174575A (zh) * | 2016-08-10 | 2016-12-07 | 孔令娇 | 一种具有改善睡眠质量功效的糯米糕 |
-
2017
- 2017-06-15 CN CN201710450308.XA patent/CN107259530A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102150831A (zh) * | 2010-12-03 | 2011-08-17 | 郑延明 | 改善睡眠的无花果山药天然果珍及其制备方法 |
CN103463625A (zh) * | 2013-09-22 | 2013-12-25 | 山西康禾农业有限责任公司 | 养心补血营养制剂 |
CN103609958A (zh) * | 2013-11-30 | 2014-03-05 | 大连润扬科技发展有限公司 | 一种补脑营养保健粥品 |
CN103704568A (zh) * | 2013-12-07 | 2014-04-09 | 山西康禾农业有限责任公司 | 临床膳食食品 |
CN105495614A (zh) * | 2015-12-25 | 2016-04-20 | 梁燕妮 | 治疗失眠的速食粉及其制备方法 |
CN106174575A (zh) * | 2016-08-10 | 2016-12-07 | 孔令娇 | 一种具有改善睡眠质量功效的糯米糕 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020153908A3 (en) * | 2019-01-23 | 2020-09-17 | Agency For Science, Technology And Research (A*Star) | Pre-natal beta-cryptoxanthin benefits children |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (zh) | 预防糖尿病的保健食品 | |
CN107173694A (zh) | 一种营养全面平衡的全素食代餐粉配方 | |
CN101473953B (zh) | 净血排毒组合食品及其加工方法和应用 | |
CN106722963A (zh) | 一种素食餐 | |
CN103416625B (zh) | 一种大麦型仔猪饲料及其制备方法 | |
CN102813120B (zh) | 海参防癌降糖面粉及制备方法 | |
CN103652361A (zh) | 一种产后1-20天哺乳期母猪饲料及其制备方法 | |
CN103355544B (zh) | 一种哺乳期母猪饲料 | |
CN106107463A (zh) | 超级藜麦抗疲劳奶茶制作工艺 | |
CN105707707A (zh) | 藜麦孕产妇超级营养粉 | |
CN108887564A (zh) | 一种硒蛋白杂粮粉配方及其制备方法 | |
CN106858215A (zh) | 一种百香果复合饮料 | |
CN110327421A (zh) | 一种适合宇航员具有提高精力和协调人体各器官功能的组合物 | |
CN112369577A (zh) | 一种阻糖美容组合物及其制备方法 | |
CN103461585B (zh) | 补气养生中药茶 | |
CN101946895B (zh) | 一种以泥鳅为主料的功能食品及其制备方法 | |
CN103704568B (zh) | 临床膳食食品 | |
CN103463625B (zh) | 养心补血营养制剂 | |
CN105994748A (zh) | 老青海青稞酥油茶 | |
CN105249440A (zh) | 一种阿胶糕 | |
CN102090637A (zh) | 一种含有胶原蛋白的复方营养粉 | |
CN110638038A (zh) | 一种用于控制高血糖的医学配方营养代餐粉及其制备方法 | |
CN106174286A (zh) | 高级金枸杞营养果酱 | |
CN109730222A (zh) | 酵素复合液及其保健饮料 | |
CN107259530A (zh) | 一种用于安神、改善睡眠的百香果配方食品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171020 |
|
RJ01 | Rejection of invention patent application after publication |